Clinical trial • Phase III • Infectious Disease|Dermatology|Other
Clinical trial in Burn injury
Phase III trial for Burn injury. 82 participants.
Overview
- Trial Therapeutic Area
- Infectious Disease|Dermatology|Other
- Trial Disease
- Burn injury
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 13-09-2024
- First CTIS Authorization Date
- 14-10-2024
Trial design
Phase III trial across 1 site in Austria.
- Target Sample Size
- 82
Eligibility
Recruits 82 Vulnerable populations selected; no details on consent or assent handling provided in the record..
- Vulnerable Population
- Vulnerable populations selected; no details on consent or assent handling provided in the record.
Recruitment
- Planned Sample Size
- 82
- Recruitment Window Months
- 141
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 82
Austria
- Earliest CTIS Part Ii Submission Date
- 23-09-2024
- Latest Decision Or Authorization Date
- 14-10-2024
- Processing Time Days
- 21
- Number Of Sites
- 1
- Number Of Participants
- 82
Sites
- Site Name
- Medical University Of Vienna
- Department Name
- Department of Clinical Pharmacology
- Principal Investigator Name
- Markus Zeitlinger
- Principal Investigator Email
- markus.zeitlinger@meduniwien.ac.at
- Contact Person Name
- Markus Zeitlinger
- Contact Person Email
- markus.zeitlinger@meduniwien.ac.at
Sponsor
Primary sponsor
- Full Name
- Medical University Of Vienna
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Austria
Related trials
Other published trials that may interest you.